asa glp 1 agonists Anesthetic Considerations for Patients Taking Glucagon-Like Peptide-1 GLP-1 receptor agonists and next-generation
Description
Whilst such trials are required to ensure medically appropriate adoption of the drug class in HF, they are also strongly warranted considering the current scarcity of pharmacotherapeutic options in HF (especially HFpEF), which remains one of the CVDs with markedly unaddressed medical needs
Should I see a mental health specialist if Im not emotionally ready to lose weight
Liraglutide efficacy and action in non-alcoholic steatohepatitis (LEAN): study protocol for a phase II multicentre, double-blinded, randomised, controlled trial
New antidiabetic and anti-obesity drugs
The expression of GLP-1s in genetically modified plants has been found to present a promising cost-effective approach for treating type 2 diabetes mellitus
doi:10.1016/j.molmet.2018.05.014 52
